Increasing Investments For Development Of New Biotechnological Diagnostic Techniques To Drive Nucleic Acid Amplification Test Market Till 2025: Grand View Research,Inc.
The global nucleic acid amplification test (NAAT) market is
expected to reach USD 4.4 Billion by 2025, according to a new report by Grand
View Research, Inc. Nucleic acid amplification testing is gaining preference
over traditional diagnostic techniques because of its high efficiency and
accuracy. In addition, the potential application of these tests in various
life-threatening diseases, including several types of cancer, is attracting a
large amount of investment for the purpose of R&D. Increasing number of
ongoing studies are expected to ensure higher growth rate in the later part of
the forecast period.
These tests are currently being
used extensively for screening and diagnosis of a wide range of infectious
diseases. Along with known infectious diseases, management of epidemics of new
diseases has caused a sudden surge in the demand for advanced diagnostic tests.
NAAT is currently the most advanced and efficient diagnostic method, which
extensively uses technology that helps in reducing procedural time and
consumption of reagents.
Browse full research report on Nucleic Acid Amplification
Test Market: http://www.grandviewresearch.com/industry-analysis/nucleic-acid-amplification-testing-naat-market
Further Key Findings from
the Study Suggest:
- The market study suggests that infectious diseases
segment captured the largest revenue share in 2015 owing to the high
demand for effective screening methods for management of these diseases
- Cancer is expected to exhibit the fastest growth
during the forecast period due to the rising number of studies to develop
tests for early detection of various cancer types
- Expanding applications prenatal screening and for the
detection of mitochondrial disorders is expected to boost the demand for
NAAT
- High usage of the PCR technique in NAT is driving the
growth of the segment and is expected to capture significant revenue share
in the near future
- North America dominated the space in 2015 with U.S.
capturing the largest share
- Evolution of biotechnology sector in the Asia
Pacific, along with the favorable government initiatives, Asia Pacific is
expected to show the fastest growth rate during the forecast period
- A few of the major players in the market are F.
Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Becton, Dickinson and
Company; Novartis AG; Beckman Coulter, Inc.; bioMérieux SA; Abbott
Laboratories; Siemens Healthineers, and Illumina, Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the nucleic acid
amplification test market on the basis of application, technique, and region:
Nucleic Acid Amplification Test Application Outlook
(Revenue, USD Million, 2014 - 2025)
- Infectious
Diseases
- Virus
- Bacteria
- Others
- Cancer
- Personalized
Medicine
- Genetic
and Mitochondrial Disorders
Nucleic Acid Amplification Test Technique Outlook
(Revenue, USD Million 2014 - 2025)
- Target
amplification systems
- Probe
amplification systems
- Signal
amplification
Nucleic Acid Amplification Test Regional Outlook
(Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Germany
Asia Pacific
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
Comments
Post a Comment